» Articles » PMID: 24843496

High Glucose Impairs the Proliferation and Increases the Apoptosis of Endothelial Progenitor Cells by Suppression of Akt

Abstract

Unlabelled: Aims/Introduction:  Endothelial progenitor cells (EPC) play a critical role in adult vasculogenesis and vascular repair. Previous studies have described the dysfunction of EPC in diabetic patients, but the precise mechanism is still unclear. To elucidate the dysfunction of EPC in diabetic patients, we investigated the functions and intracellular signaling of EPC under normal or high glucose conditions. We also examined the number of EPC in the peripheral blood of Japanese type 2 diabetic patients.

Materials And Methods:   EPC were cultured with normal or high glucose. Subsequently, the proliferation and the apoptosis of EPC were assessed in the presence or absence of vascular endothelial growth factor (VEGF). The phosphorylation of Akt was assessed by western blot analyses. We compared the number of CD34(+)CD45(low) progenitor cells, which is considered as a marker of EPC in non-diabetic and type 2 diabetic subjects, using flow cytometry.

Results:   High glucose decreased the proliferation of EPC and increased the number of apoptotic cells. VEGF significantly increased the proliferation and suppressed the apoptosis of EPC, both of which were abolished by PI 3-kinase inhibitor, LY294002. High glucose significantly suppressed the basal and VEGF-stimulated phosphorylation of Akt in EPC. Furthermore, the number of circulating EPC was decreased in type 2 diabetic patients, although there were no significant differences in the serum levels of VEGF between control subjects and diabetic patients.

Conclusions:   These findings suggest that high glucose impairs the functions of EPC through the suppression of Akt phosphorylation stimulated by VEGF. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00093.x, 2011).

Citing Articles

Nutrient regulation of development and cell fate decisions.

Tu W, Christofk H, Plath K Development. 2023; 150(20).

PMID: 37260407 PMC: 10281554. DOI: 10.1242/dev.199961.


Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes.

Fadini G, Albiero M Stem Cells. 2022; 40(8):716-723.

PMID: 35552468 PMC: 9406601. DOI: 10.1093/stmcls/sxac035.


Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease.

Mercier C, Rousseau M, Geraldes P Front Cardiovasc Med. 2021; 7:619612.

PMID: 33490120 PMC: 7817696. DOI: 10.3389/fcvm.2020.619612.


TUG1 enhances high glucose-impaired endothelial progenitor cell function via miR-29c-3p/PDGF-BB/Wnt signaling.

Li Y, Zhi K, Han S, Li X, Li M, Lian W Stem Cell Res Ther. 2020; 11(1):441.

PMID: 33059750 PMC: 7558752. DOI: 10.1186/s13287-020-01958-3.


Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway.

Lin F, Yang Y, Wei S, Huang X, Peng Z, Ke X Drug Des Devel Ther. 2020; 14:621-633.

PMID: 32103904 PMC: 7027865. DOI: 10.2147/DDDT.S242521.


References
1.
Cubbon R, Kahn M, Wheatcroft S . Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci (Lond). 2009; 117(5):173-90. DOI: 10.1042/CS20080263. View

2.
Urbich C, Dimmeler S . Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 2005; 67(5):1672-6. DOI: 10.1111/j.1523-1755.2005.00261.x. View

3.
Tan K, Lessieur E, Cutler A, Nerone P, Vasanji A, Asosingh K . Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy. Exp Eye Res. 2010; 91(2):229-37. PMC: 3895932. DOI: 10.1016/j.exer.2010.05.012. View

4.
Shintani S, Kusano K, Ii M, Iwakura A, Heyd L, Curry C . Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Nat Clin Pract Cardiovasc Med. 2006; 3 Suppl 1:S123-8. DOI: 10.1038/ncpcardio0430. View

5.
Mund J, Ingram D, Yoder M, Case J . Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy. 2009; 11(2):103-13. DOI: 10.1080/14653240802714827. View